Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand

Lauren H. Carlton; Tiffany Chen; Alana L. Whitcombe; Reuben McGregor; Greg Scheurich; Campbell R. Sheen; James M. Dickson; Chris Bullen; Annie Chiang; Daniel J. Exeter; Janine Paynter; Michael G. Baker; Richard Charlewood; Nicole J. Moreland

This article is a Preprint

Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.

Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand

Lauren H. Carlton; Tiffany Chen; Alana L. Whitcombe; Reuben McGregor; Greg Scheurich; Campbell R. Sheen; James M. Dickson; Chris Bullen; Annie Chiang; Daniel J. Exeter; Janine Paynter; Michael G. Baker; Richard Charlewood; Nicole J. Moreland.

Affiliation

Lauren H. Carlton; The University of Auckland, Auckland, New Zealand
Tiffany Chen; The University of Auckland, Auckland, New Zealand
Alana L. Whitcombe; The University of Auckland, Auckland, New Zealand
Reuben McGregor; The University of Auckland, Auckland, New Zealand
Greg Scheurich; The New Zealand Blood Service, Auckland, New Zealand
Campbell R. Sheen; Callaghan Innovation, Christchurch, New Zealand
James M. Dickson; The University of Auckland, Auckland, New Zealand
Chris Bullen; The University of Auckland, Auckland, New Zealand
Annie Chiang; The University of Auckland, Auckland, New Zealand
Daniel J. Exeter; The University of Auckland, Auckland, New Zealand
Janine Paynter; The University of Auckland, Auckland, New Zealand
Michael G. Baker; University of Otago, Wellington, New Zealand
Richard Charlewood; The New Zealand Blood Service, Auckland, New Zealand
Nicole J. Moreland; The University of Auckland, Auckland, New Zealand

Preprint in English | medRxiv | ID: ppmedrxiv-21255282

Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article

ABSTRACT

ABSTRACT

A large-scale SARS-CoV-2 serosurvey of New Zealand blood donors (n=9806) was conducted at the end of 2020. Seroprevalence, after adjusting for test sensitivity and specificity, was very low (0.1%). This finding is consistent with limited community transmission and provides robust evidence to support New Zealand s successful elimination strategy for COVID-19.

License

cc_by_nd

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Observational study Language: English Year: 2021 Document type: Preprint

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: Preprints Database: medRxiv Type of study: Diagnostic study / Observational study Language: English Year: 2021 Document type: Preprint